Barnes, PJ (2002) New treatments for COPD. Nat Rev Drug Discov 1: pp. 437-446Barnes PJ (2002) New treatments for COPD. Nat Rev Drug Discov 1 :437–446 View ArticleBarnes PJ. New treatments for COPD. Nat Rev Drug Discov. 2002; 1 :437–446. doi: 10.1038/nrd820. [ Cross Ref ]...
COPD is one of the most common diseases in the world, and there is a global increase in prevalence, but there are no drugs available at present that halt the relentless progression of this disease. However, a better understanding of the cellular and mole
COPD ... N. Gross - 《Copd Journal of Chronic Obstructive Pulmonary Disease》 被引量: 25发表: 2004年 Novel Anti-Inflammatory Treatments for Asthma and COPD Summary This chapter contains sections titled: Introduction Current asthma and COPD therapies The need for new therapies Improving current ...
MiRNA lct-7c low expression in COPD can regulate inflammatory responses by targeting STAT3 in alveolar macrophage,which may provide a new target for COPD ... Ji-Hui,Yu,Li,... - 《亚太热带医药杂志(英文版)》 被引量: 7发表: 2016年 加载更多来源...
may lead to worse outcomes for some patients with chronic obstructive pulmonary disease (COPD). The discovery may help identify patients at higher risk for COPD progression, who might also show little benefit from standard treatments. The study was presented at the ATS 2016 International Conference....
Magnetic resonance imaging nanoprobe quantifies nitric oxide for evaluating M1/M2 macrophage polarization and prognosis of cancer treatments. ACS Nano. 2023;17(24):24854–66. Article CAS PubMed Google Scholar Ashrafizadeh M, Zarrabi A, Bigham A, Taheriazam A, Saghari Y, Mirzaei S, et al....
in our understanding of how the lung works in both normal conditions and duringdisease. The fundamental biochemical process that we have discovered will ultimately allow us to better design ways to develop new treatments for those suffering from asthma and chronic obstructive pulmonary disease (COPD)...
However, whereas severe asthma patients with high eosinophilic levels might benefit from anti-eosinophil therapies, including blocking antibodies against IL-5, IL-13 and IL-33 (Barnes, 2015), it yet has to be proven if these immunotherapeutic treatments are beneficial for (a subgroup of) COPD ...
‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage Who could achieve remission? Some people with asthma are more likely to achieve clinical remission than others. When appropriate treatments are started as soon as possible, and...
NF-κB: Nuclear factor κB DCM: Dilated cardiomyopathy CVB3: Coxsackievirus B3 B19V: Human parvovirus B19 SARS-CoV-2: Severe acute respiratory syndrome-2 EM: Eosinophilic myocarditis EAM: Experimental autoimmune myocarditis CS: Cardiac sarcoidosis ...